BioCentury
ARTICLE | Clinical News

Fycompa perampanel regulatory update

October 28, 2013 7:00 AM UTC

Eisai said Israel approved Fycompa perampanel as an adjunctive treatment for partial onset seizures, with or without secondary generalization, in patients with epilepsy ages >=12 years. Eisai said the...